Program Structure

Module 1: Introduction to Nanobiopharmaceuticals

• Overview of nanotechnology in pharmaceuticals and drug delivery.
• Importance of nanobiopharmaceuticals in overcoming challenges like drug resistance and side effects.
• Understanding nanocarriers and their role in targeted and controlled drug delivery.

Module 2: Types of Nanocarriers Used in Drug Delivery

• Understanding liposomes, micelles, dendrimers, polymeric nanoparticles, and solid lipid nanoparticles as drug delivery vehicles.
• How surface modification enhances drug targeting and drug release capabilities.
• Exploring the unique advantages and disadvantages of different nanocarriers for specific therapeutic applications.

Module 3: Design and Engineering of Nanobiopharmaceuticals

• Design principles for nanocarriers: size, surface charge, and stability.
• Techniques for encapsulation, drug loading, and controlled release.
• Optimizing nanocarrier properties for site-specific delivery (e.g., cancer cells, inflamed tissues, brain).

Module 4: Targeted Drug Delivery Systems

• Mechanisms of targeted drug delivery: active vs. passive targeting, receptor-mediated delivery.
• Designing nanocarriers to target specific tissues, such as tumors, the brain, and infection sites.
• Examples of nanobiopharmaceuticals used in chemotherapy, gene therapy, and vaccines.

Module 5: Nanobiopharmaceuticals in Cancer Therapy

• Role of nanoparticles in delivering chemotherapeutic drugs to tumor cells with high efficacy and minimal side effects.
• Passive targeting (EPR effect) and active targeting (ligand-mediated delivery) strategies in cancer treatment.
• Case studies: Success stories of nanobiopharmaceuticals in oncology.

Module 6: Nanobiopharmaceuticals in Gene Therapy

• Exploring nanotechnology for gene delivery systems, including DNA, RNA, and CRISPR-based therapies.
• The challenges of delivering genetic material to target cells and how nanomaterials can improve efficiency.
• Case studies: nanoparticle-based delivery systems for gene therapy in treating genetic disorders.

Module 7: Nanotechnology in Neurological Disorders

• Challenges in delivering therapeutic agents to the central nervous system (CNS) through the blood-brain barrier (BBB).
• Nanoparticles for targeted drug delivery to treat Alzheimer’s, Parkinson’s, and other neurological conditions.
• Examples of nanopharmaceuticals in clinical development for treating neurological conditions.

Module 8: Safety, Toxicity, and Regulatory Considerations

• Safety and toxicity concerns surrounding nanoparticles and their potential risks to human health and the environment.
• The importance of biocompatibility and long-term stability in nanoparticle-based systems.
• Regulatory hurdles in nanomedicine: guidelines, approval processes, and clinical trial requirements.

Module 9: Future Trends in Nanobiopharmaceuticals in Targeted Therapy

• Emerging trends in nanobiopharmaceuticals: smart drug delivery, multi-functional nanocarriers, and theranostics.
• How personalized medicine is driving the development of nanopharmaceuticals for individual patients.
• Future applications: advanced cancer therapies, gene editing techniques, and neurodegenerative disease treatments.

Final Project

• Design a nanocarrier-based drug delivery system for a specific therapeutic target (e.g., cancer therapy, gene delivery, neurological treatment).
• Synthesize the nanocarrier, characterize its properties, and evaluate its drug delivery efficiency and targeting specificity.
• Example projects: Design a nanoparticle-based chemotherapy delivery system or a gene delivery nanoparticle for targeted treatment of genetic disorders.